GanT Maintained at Outperform
Oppenheimer maintains Outperform rating on Gain Therapeutics. No change to estimates.
Oppenheimer maintains Outperform rating on Gain Therapeutics.
No change to estimates.
Oppenheimer maintains Outperform rating on Gain Therapeutics. No change to estimates.
Oppenheimer maintains Outperform rating on Gain Therapeutics.
No change to estimates.